Themis Bioscience GmbH
8 clinical trials · Sponsor
◉ Watch Themis Bioscience GmbH
| Record | Firm | Date |
|---|---|---|
| A Trial to Evaluate the Optimal Dose of MV-LASV (V182-001) (NCT04055454) | Themis Bioscience GmbH | 2019-09-26 |
| Safety and Immunogenicity of a Novel Vaccine Formulation MV-ZIKA-RSP (V187-001) (NCT04033068) | Themis Bioscience GmbH | 2019-08-02 |
| Chikungunya Vaccine (V184) Study in Previously Exposed Adults (V184-006) (NCT03807843) | Themis Bioscience GmbH | 2019-07-16 |
| Safety, Tolerability and Long-term Immunogenicity of Different Formulations of a Chikungunya Vaccine (V184-005) (NCT03635086) | Themis Bioscience GmbH | 2018-08-22 |
Track Themis Bioscience GmbH automatically
Every clearance here is in the API, with alerts when new ones post.